A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors
Clinical trial NCT03486314 · COMPLETED
Trial details
- NCT number
- NCT03486314
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-13
- Primary completion
- 2019-05-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.